Mineralys Therapeutics, Inc. Insider Transactions
Mineralys Therapeutics, Inc. Insider Trades History
Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
---|---|---|---|---|---|---|---|
Slingsby Brian Taylor
Director, 10 percent owner: |
Sell | 550,000 @ $13.05 | $7.18 M | 8,644,579 | 07/24/2024 | 07/26/2024 | |
Rodman David Malcom
Chief Medical Officer |
Sell | 525 @ $15.00 | $7,876 | 102,873 | 07/16/2024 | 07/18/2024 | |
Levy Adam Scott
CFO and Secretary |
Sell | 10,757 @ $13.14 | $141,394 | 247,611 | 07/11/2024 | 07/12/2024 | |
Congleton Jon
CEO |
Sell | 15,746 @ $13.34 | $210,075 | 911,212 | 07/11/2024 | 07/12/2024 | |
Congleton Jon
CEO |
Sell | 14,940 @ $11.73 | $175,237 | 926,958 | 06/20/2024 | 06/20/2024 | |
Congleton Jon
CEO |
Sell | 16,607 @ $11.99 | $199,073 | 941,898 | 06/18/2024 | 06/20/2024 | |
Congleton Jon
CEO |
Sell | 17,766 @ $12.25 | $217,712 | 958,505 | 06/17/2024 | 06/20/2024 | |
Congleton Jon
CEO |
Sell | 16,229 @ $12.52 | $203,163 | 976,271 | 06/14/2024 | 06/14/2024 | |
Congleton Jon
CEO |
Sell | 39,961 @ $12.74 | $509,027 | 992,500 | 06/13/2024 | 06/14/2024 | |
Congleton Jon
CEO |
Sell | 16,607 @ $12.77 | $212,013 | 1,032,461 | 06/12/2024 | 06/14/2024 | |
Levy Adam Scott
CFO and Secretary |
Sell | 96,815 @ $12.94 | $1.25 M | 255,462 | 06/11/2024 | 06/13/2024 | |
Rodman David Malcom
Chief Medical Officer |
Sell | 100 @ $15.00 | $1,500 | 66,997 | 05/09/2024 | 05/10/2024 | |
Samsara BioCapital GP, LLC
10 percent owner |
Buy | 555,555 @ $13.50 | $7.50 M | 5,074,916 | 02/12/2024 | 02/14/2024 | |
Congleton Jon
CEO |
Buy | 4,250 @ $5.97 | $25,356 | 1,049,068 | 11/22/2023 | 11/27/2023 | |
Congleton Jon
CEO |
Buy | 2,250 @ $12.08 | $27,180 | 1,044,818 | 09/06/2023 | 09/08/2023 | |
Congleton Jon
CEO |
Buy | 2,250 @ $12.10 | $27,225 | 1,042,568 | 08/17/2023 | 08/21/2023 | |
Rodman David Malcom
Chief Medical Officer |
Sell | 76,182 @ $12.81 | $975,891 | 0 | 08/11/2023 | 08/11/2023 | |
Congleton Jon
CEO |
Buy | 2,000 @ $12.89 | $25,780 | 1,040,318 | 08/11/2023 | 08/11/2023 | |
Rodman David Malcom
Chief Medical Officer |
Sell | 74,625 @ $13.16 | $982,065 | 0 | 08/10/2023 | 08/11/2023 | |
HBM Healthcare Investments (Cayman) Ltd.
10 percent owner |
Buy | 312,500 @ $16.00 | $5.00 M | 3,218,106 | 02/14/2023 | 02/16/2023 |
Mineralys Therapeutics, Inc. FAQ's
The list of insiders at Mineralys Therapeutics, Inc. includes Samsara BioCapital GP, LLC, Rodman David Malcom, Levy Adam Scott, Congleton Jon, Slingsby Brian Taylor.
Insiders have sold a total of 796,053 Mineralys Therapeutics, Inc. shares in the last 12 months for a total of 10.31 M sold.
The following insiders have sold Mineralys Therapeutics, Inc. shares in the last 12 months: Rodman David Malcom ($9,376), Levy Adam Scott ($1.39 M), Congleton Jon ($1.73 M), Slingsby Brian Taylor ($7.18 M),
Insiders have purchased a total of 555,555 Mineralys Therapeutics, Inc. shares in the last 12 months for a total of 7.50 M sold.
The following insiders have purchased Mineralys Therapeutics, Inc. shares in the last 12 months: Samsara BioCapital GP, LLC ($7.50 M),